Guangzhou Jet Bio-Filtration Co Ltd
SSE:688026
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Guangzhou Jet Bio-Filtration Co Ltd
Long-Term Investments
Guangzhou Jet Bio-Filtration Co Ltd
Long-Term Investments Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Guangzhou Jet Bio-Filtration Co Ltd
SSE:688026
|
Long-Term Investments
¥256m
|
CAGR 3-Years
103%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Shanghai Conant Optical Co Ltd
HKEX:2276
|
Long-Term Investments
¥79.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Long-Term Investments
¥207.1m
|
CAGR 3-Years
54%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Winner Medical Co Ltd
SZSE:300888
|
Long-Term Investments
¥2.4B
|
CAGR 3-Years
421%
|
CAGR 5-Years
206%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Long-Term Investments
¥2.1B
|
CAGR 3-Years
101%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
|
|
Intco Medical Technology Co Ltd
SZSE:300677
|
Long-Term Investments
¥2.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
130%
|
CAGR 10-Years
N/A
|
|
Guangzhou Jet Bio-Filtration Co Ltd
Glance View
Guangzhou Jet Biofiltration Co., Ltd. engages in the research and development, manufacture, and sale of biological laboratory consumables. The company is headquartered in Guangzhou, Guangdong and currently employs 1,431 full-time employees. The company went IPO on 2020-01-22. The firm focuses on disposable plastic consumables for cell culture and related liquid handling biological laboratories. Its main products include biological culture type and liquid handling type, as well as reagents and small laboratory equipment. The firm distributes its products in domestic and to overseas markets.
See Also
What is Guangzhou Jet Bio-Filtration Co Ltd's Long-Term Investments?
Long-Term Investments
256m
CNY
Based on the financial report for Dec 31, 2024, Guangzhou Jet Bio-Filtration Co Ltd's Long-Term Investments amounts to 256m CNY.
What is Guangzhou Jet Bio-Filtration Co Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
103%
Over the last year, the Long-Term Investments growth was 4%. The average annual Long-Term Investments growth rates for Guangzhou Jet Bio-Filtration Co Ltd have been 103% over the past three years .
